Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Quaker Partners, originally founded as Quaker BioVentures in 2002, has transitioned from a focus on pure biotech to a broader investment strategy encompassing various sectors within healthcare. Based in Philadelphia, PA, the firm has established itself as a significant player in the East Coast healthcare venture capital ecosystem. Quaker Partners manages over $700 million in committed capital and has evolved its investment approach to support companies at all stages of development, from Friends & Family rounds to IPOs.
The firm has undergone a rebranding to reflect its strategic shift towards diversified healthcare investing, moving beyond its initial focus on biotechnology. This evolution has allowed Quaker Partners to engage with a wider array of healthcare subsectors, including pharmaceuticals, medical devices, and healthcare services. The firm has achieved notable milestones, including successful exits such as Neuronetics and TELA Bio, which have contributed to its reputation in the venture capital community.
Quaker Partners invests across a diverse range of healthcare subsectors, including biotech, pharmaceuticals, medical devices, clinical diagnostics, health platforms, telemedicine, and digital health. The firm targets companies at various stages of development, from early-stage startups to more mature businesses preparing for IPOs. Their investment strategy emphasizes identifying and supporting companies that are commercializing innovative products and technologies aimed at improving patient outcomes.
The firm’s check sizes vary depending on the stage of investment, covering all stages from Friends & Family to Series E and beyond. Quaker Partners seeks to partner with founders who demonstrate a strong vision and the capability to navigate the complexities of the healthcare market. Their approach includes providing strategic guidance and leveraging their extensive network of healthcare professionals and investors to enhance portfolio company growth.
Quaker Partners has built a notable portfolio of companies that represent a range of innovative solutions in the healthcare space. Key portfolio companies include:
These companies exemplify Quaker Partners' commitment to supporting innovative healthcare solutions that address critical needs in the market.
P. Sherrill Neff - Co-founder and Founding Partner. Neff has a background in healthcare investment banking and corporate development, bringing extensive experience in the healthcare sector.
Brenda Gavin - Co-founder. Gavin has played a pivotal role in shaping the firm's investment strategy and portfolio management.
Ira Lubert - Co-founder. Lubert is a well-known Philadelphia investor and philanthropist, contributing significant expertise and connections to the firm.
Geeta Vemuri - Partner. Vemuri has a strong background in healthcare investments and is involved in sourcing and managing portfolio companies.
To pitch Quaker Partners, founders should send an email to webmaster@quakerpartners.com with a comprehensive pitch deck. The deck should include details about the business model, market opportunity, competitive landscape, and team qualifications. Founders should expect a response within a few weeks, although timelines may vary based on the firm's current activity.
Warm introductions are preferred, but not mandatory. Including relevant connections can enhance the chances of a favorable review.
As of 2024, Quaker Partners is reportedly not making new investments, indicating a potential shift towards a harvest or wind-down phase. The firm has completed a total of approximately 16 exits throughout its history, with notable successes including Neuronetics and TELA Bio, both of which went public.
Quaker Partners was originally founded as Quaker BioVentures in 2002 and rebranded to reflect its diversified healthcare investment strategy. The firm has been recognized as a cornerstone of the Philadelphia healthcare venture capital community.
What are Quaker Partners' investment criteria?
Quaker Partners invests in healthcare companies across various subsectors, including pharmaceuticals, medical devices, and healthcare services. They focus on companies that are commercializing innovative products and technologies aimed at improving patient outcomes.
How can I pitch to Quaker Partners?
Founders can reach out to Quaker Partners via email at webmaster@quakerpartners.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Quaker Partners different from other VC firms?
Quaker Partners has a long-standing presence in the healthcare venture capital space, with a strategic focus on diversified healthcare investing. Their extensive experience and network in the healthcare sector provide unique advantages to portfolio companies.
What is the geographic focus of Quaker Partners?
The firm primarily invests in North America, with a strong emphasis on the United States. This geographic focus allows them to leverage local market knowledge and connections.
What is the typical check size for investments?
Quaker Partners invests across all stages of development, which means check sizes can vary significantly. They participate in rounds from Friends & Family to Series E and beyond, adapting their investment size to the specific needs of the company.
What kind of support do portfolio companies receive?
Quaker Partners adds value through strategic guidance, industry expertise, and access to a robust network of healthcare professionals and investors. They help portfolio companies navigate challenges and capitalize on growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.